company background image
603439 logo

Guizhou Sanli PharmaceuticalLtd SHSE:603439 Stock Report

Last Price

CN¥15.80

Market Cap

CN¥6.5b

7D

-8.2%

1Y

-7.7%

Updated

27 Mar, 2024

Data

Company Financials +

Guizhou Sanli Pharmaceutical Co.,Ltd

SHSE:603439 Stock Report

Market Cap: CN¥6.5b

603439 Stock Overview

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products.

603439 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance5/6
Financial Health5/6
Dividends3/6

Guizhou Sanli Pharmaceutical Co.,Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Guizhou Sanli PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥15.80
52 Week HighCN¥20.65
52 Week LowCN¥11.92
Beta0.76
1 Month Change-0.50%
3 Month Change-12.51%
1 Year Change-7.71%
3 Year Change-17.02%
5 Year Changen/a
Change since IPO49.34%

Recent News & Updates

Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly

Mar 25
Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly

Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Mar 06
Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Recent updates

Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly

Mar 25
Guizhou Sanli PharmaceuticalLtd (SHSE:603439) Seems To Use Debt Rather Sparingly

Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Mar 06
Guizhou Sanli Pharmaceutical Co.,Ltd's (SHSE:603439) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Shareholder Returns

603439CN PharmaceuticalsCN Market
7D-8.2%-4.3%-4.9%
1Y-7.7%-11.8%-16.6%

Return vs Industry: 603439 exceeded the CN Pharmaceuticals industry which returned -11.4% over the past year.

Return vs Market: 603439 exceeded the CN Market which returned -14.8% over the past year.

Price Volatility

Is 603439's price volatile compared to industry and market?
603439 volatility
603439 Average Weekly Movement8.1%
Pharmaceuticals Industry Average Movement7.0%
Market Average Movement8.2%
10% most volatile stocks in CN Market11.5%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 603439 has not had significant price volatility in the past 3 months.

Volatility Over Time: 603439's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19951,557Hai Zhanghttps://www.gz-sanli.com

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular drugs, injury by fall medication, rehabilitation medicine, GI medicine, and ophthalmic medicine.

Guizhou Sanli Pharmaceutical Co.,Ltd Fundamentals Summary

How do Guizhou Sanli PharmaceuticalLtd's earnings and revenue compare to its market cap?
603439 fundamental statistics
Market capCN¥6.48b
Earnings (TTM)CN¥255.61m
Revenue (TTM)CN¥1.46b

25.3x

P/E Ratio

4.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603439 income statement (TTM)
RevenueCN¥1.46b
Cost of RevenueCN¥387.94m
Gross ProfitCN¥1.07b
Other ExpensesCN¥817.13m
EarningsCN¥255.61m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Apr 27, 2024

Earnings per share (EPS)0.62
Gross Margin73.44%
Net Profit Margin17.50%
Debt/Equity Ratio14.3%

How did 603439 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

16%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.